Previous Close | 5.63 |
Open | 5.61 |
Bid | 5.65 x N/A |
Ask | 5.72 x N/A |
Day's Range | 5.30 - 5.72 |
52 Week Range | 5.00 - 12.62 |
Volume | 23,312 |
Avg. Volume | 51,103 |
Market Cap | 502.957M |
Beta (5Y Monthly) | 1.13 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.65 |
Earnings Date | Nov. 10, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.00 |
Aerpio (ARPO) unveils strategic alternatives after it announced top-line results from a phase II study of razuprotafib in glaucoma patients in December.
Novo Nordisk (NVO) files for a label expansion of Ozempic in the EU to include a new dose of 2.0 mg.
Aptose Biosciences (APTO) has been struggling lately, but the selling pressure may be coming to an end soon.